
Duke Street backs MBO of Kent and Athlone from DCC
Duke Street has backed the management buyout of UK and Irish pharmaceuticals companies Kent Pharmaceuticals and Athlone Laboratories from trade vendor DCC Vital.
Financial details of the transaction remain undisclosed, though Duke Street typically invests in companies with enterprise values of £50-350m.
Sky News recently reported that Kent and Athlone represent a small portion of DCC's healthcare division, which itself accounts for 13% of the listed firm's profits. DCC has a market cap of £6.5bn.
The businesses will form the basis for an acquisitive growth strategy and will invest in the expansion of its range of products.
Duke Street has introduced former Wyeth Laboratories managing director Kevin James as non-executive chairperson at the new group.
Apera provided a term debt facility to support the transaction, in addition to an acquisition facility for future bolt-ons.
Company
Headquartered in Ashford and founded in 1986, Kent is a manufacturer and distributor of off-patent generic pharmaceuticals, including analgesics and penicillin. The business primarily sells its products through hospitals and pharmacy wholesalers.
Athlone is headquartered in Ballymurray, County Roscommon, and manufactures specialist beta-lactum antibiotics.
People
Duke Street – Charlie Troup (managing partner).
Kent Pharmaceuticals & Athlone Laboratories – Debashis Dasgupta (CEO).
Advisers
Equity – Results Healthcare (corporate finance); DLA Piper (legal); Goodwin Procter (legal).
Management – Liberty Corporate Finance (corporate finance).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater